Bone Biologics (BBLGW) Stock Price, News & Analysis

Company Overview

Bone Biologics, Inc. is a clinical-stage biopharmaceutical company focused on developing protein-based therapeutics designed to promote bone healing and regeneration in acute and chronic orthopedic conditions. Its proprietary platform combines key osteogenic growth factors with engineered delivery matrices to support repair in complex fractures, spinal fusion procedures and non-union bone injuries. By targeting the biology of bone formation, the company aims to overcome limitations associated with autografts, allografts and synthetic implants.

The company’s lead candidate is advancing through preclinical evaluation, with studies assessing efficacy in animal models of fracture repair and spinal arthrodesis. Bone Biologics’ sustained-release approach delivers synergistic combinations of bone growth proteins and immunomodulators directly to injury sites, potentially reducing healing times and improving structural outcomes. Strategic collaborations with academic research centers and orthopedic specialists bolster its pipeline development and pave the way for future clinical trials in North America.

Headquartered in the United States, Bone Biologics is guided by a management team with deep expertise in biopharmaceutical research, orthopedic science and regenerative medicine. The leadership group brings together experience in protein engineering, clinical development and commercialization strategy, positioning the company to advance toward translational milestones. As Bone Biologics seeks to broaden its product portfolio, it remains committed to addressing unmet medical needs in bone health through innovative biologic therapies.

Key Stats

• Today's Range: $10.39 to $10.39
• 50-Day Range: $9.11 to $15.00
• 52-Week Range: $3.00 to $95.04
• Volume: N/A
• Average Volume: 1,786 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BBLGW Stock Analysis - Frequently Asked Questions

How have BBLGW shares performed this year?

Bone Biologics' stock was trading at $40.00 at the start of the year. Since then, BBLGW stock has decreased by 74.0% and is now trading at $10.39.

When did Bone Biologics' stock split?

Bone Biologics's stock reverse split on the morning of Wednesday, June 7th 2023.The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Bone Biologics?

Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BBLGW
• CIK: 1419554
• Web: www.bonebiologics.com
• Phone: 781-552-4452
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A